Biologische Beschichtung von Implantaten mit rhBMP-2

  • G. Voggenreiter
  • K. Hartl
  • S. Assenmacher
  • M. Chatzinikolaidou
  • H. P. Jennissen
Conference paper
Part of the Deutsche Gesellschaft für Chirurgie book series (DTGESCHIR, volume 30)

Biocoating of implants with rhBMP-2

Abstract

A concept and methodology were developed for the direct biocoating of implantable metals, like titanium and stainless steel, with bioactive factors such as bone morphogenetic proteins (BMP) for future application as cementless bone prostheses. Recombinant human BMP-2 (rhBMP-2) was expressed in E. coli and purified in biologically active form. Small electropolished titanium plates were “surface-enhanced” by a novel treatment with chromosulfuric acid and then coated with rhBMP-2. Treatment with chromosulfuric acid led to a very hydrophilic surface with a five-fold higher binding capacity for protein. In vivo testing was initated employing a periostal flap test model in rabbits. In the animal model it could be shown that the biocoated implants are non-toxic and the overall in vivo biological activity of rhBMP-2 biocoated implants (insoluble BMP-2) is so high that it is comparable to that of soluble rhBMP-2 controls, only that in the latter case the BMP effect is neither limited nor targeted and poses the danger of ectopic bone formation. We conclude that surfaces of biomaterials can be tailored by our method in such a way that a selective and specific interaction (“biological recognition”) with the target tissue can be induced by immobilized rhBMP-2 with minimal danger of ectopic bone formation and without eliciting a significant inflammatory response.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Jennissen HP, Zumbrink T, Chatzinikolaidou M, Steppuhn J (1999) Biocoating of implants with mediator molecules: Surface enhancement of metals by treatment with chromosulfuric acid. Materialwiss Werkstofftech 30: 838–845CrossRefGoogle Scholar
  2. 2.
    Zegzula HD, Buck DC, Brekke J, Wozney JM, Hollinger JO (1997) Bone formation with the use of rhBMP-2. Bone Joint Surg 79-A: 1778–1790Google Scholar
  3. 3.
    Heckmann JD, Ehler W, Brooks BP, Aufdemorte TB, Lohmann CH, Morgan T, Boyan BD (1999) Bone morphogenetic protein but not fibroblast growth factor-ß enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer. Bone Joint Surg 81-A: 1717–1729Google Scholar
  4. 4.
    Jennissen HP, Zumbrink T (1999) Protein immobilization on metal implant surfaces with potential for biocoating with BMP’s. FASEB J 13: A427Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2001

Authors and Affiliations

  • G. Voggenreiter
    • 1
  • K. Hartl
    • 1
  • S. Assenmacher
    • 1
  • M. Chatzinikolaidou
    • 1
  • H. P. Jennissen
    • 1
  1. 1.Klinik für UnfallchirurgieUniversitätsklinikum Mannheim gGmbHGermany

Personalised recommendations